发明公开
- 专利标题： NEW COMPOUNDS
-
申请号： EP16770011.1申请日： 2016-09-22
-
公开(公告)号： EP3353177A1公开(公告)日： 2018-08-01
- 发明人: ANGIBAUD, Patrick, René , BROGGINI, Diego, Fernando, Domenico , COLOMBEL, Hélène, France, Solange , CUYCKENS, Filip, Albert, C , HOSTYN, Steven, Anna , JONES, Russell, Mark , QUEROLLE, Olivier, Alexis, Georges , VERMEULEN, Wim
- 申请人： Janssen Pharmaceutica, N.V.
- 申请人地址： Turnhoutseweg 30 2340 Beerse BE
- 专利权人： Janssen Pharmaceutica, N.V.
- 当前专利权人： Janssen Pharmaceutica, N.V.
- 当前专利权人地址： Turnhoutseweg 30 2340 Beerse BE
- 代理机构： Vervoort, Liesbeth
- 优先权： EP15186491 20150923
- 国际公布： WO2017050864 20170330
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; C07D487/04 ; A61K31/519 ; A61P35/00
摘要：
The invention relates to new quinoxaline, quinoline and quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
公开/授权文献
- EP3353177B1 TRICYCLIC HETEROCYCLES FOR THE TREATMENT OF CANCER 公开/授权日：2020-06-03
信息查询
